Back to results
US 10,308,608 B2Granted
Histone deacetylase inhibitors
AssigneeBiomarin Pharmaceutical Inc.
InventorsShripad Bhagwat, Gregory Luedtke, Alexander Bridges
Life of this patent
Estimating the term…
Abstract
Provided herein are compounds and methods for inhibiting histone deacetylase (“HDAC”) enzymes (e.g., HDAC1, HDAC2, and HDAC3).
Claims14
A compound selected from the group consisting of:
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.